Q3 2024 Holdings
Filed 2024-11-14 | 75 holdings | $1.8B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ELI Lilly & Co(LLY) | COM | 532457108 | $264.6M | 298,643 | 15.0% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $98.0M | 589,409 | 5.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $92.8M | 1,757,192 | 5.3% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $79.8M | 403,861 | 4.5% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $69.2M | 148,852 | 3.9% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $67.5M | 137,327 | 3.8% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $61.6M | 542,811 | 3.5% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $50.7M | 124,840 | 2.9% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $49.0M | 213,983 | 2.8% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $48.2M | 97,498 | 2.7% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $47.1M | 86,832 | 2.7% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $44.2M | 75,588 | 2.5% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $43.5M | 686,150 | 2.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $42.0M | 467,427 | 2.4% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $36.1M | 58,433 | 2.0% |
| Danaher Corporation(DHR) | COM | 235851102 | $34.9M | 125,515 | 2.0% |
| Icon PLC(ICLR) | SHS | G4705A100 | $33.5M | 116,532 | 1.9% |
| Penumbra Inc(PEN) | COM | 70975L107 | $32.3M | 166,261 | 1.8% |
| Humana Inc(HUM) | COM | 444859102 | $32.3M | 101,954 | 1.8% |
| Elevance Health Inc(ELV) | COM | 036752103 | $29.3M | 56,441 | 1.7% |
| Amgen Inc(AMGN) | COM | 031162100 | $29.1M | 90,297 | 1.6% |
| Ascendis Pharma A/S | NOTE 2.250% 4/0 | 04351PAD3 | $26.8M | $23,000,000 | 1.5% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $26.5M | 111,854 | 1.5% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $25.8M | 390,863 | 1.5% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $24.5M | 101,680 | 1.4% |
| Stryker Corporation(SYK) | COM | 863667101 | $24.2M | 67,014 | 1.4% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $24.1M | 70,088 | 1.4% |
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $21.6M | 218,200 | 1.2% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $20.8M | 98,322 | 1.2% |
| Waters Corp(WAT) | COM | 941848103 | $18.4M | 51,063 | 1.0% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $18.3M | 860,821 | 1.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $16.6M | 2,742,936 | 0.9% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $13.6M | 90,766 | 0.8% |
| Erasca Inc(ERAS) | COM | 29479A108 | $13.3M | 4,876,911 | 0.8% |
| Spdr SER TR(XBI) | S&P BIOTECH | 78464A870 | $12.0M | 121,845 | 0.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $11.1M | 152,228 | 0.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $11.0M | 88,216 | 0.6% |
| Celcuity Inc(CELC) | COM | 15102K100 | $10.6M | 710,255 | 0.6% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $10.5M | 183,092 | 0.6% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $9.5M | 10,000,787 | 0.5% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $9.1M | 108,469 | 0.5% |
| Sarepta Therapeutics Inc | NOTE 1.250% 9/1 | 803607AD2 | $8.8M | $7,750,000 | 0.5% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $8.4M | 4,306,671 | 0.5% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $8.2M | 423,910 | 0.5% |
| Werewolf Therapeutics Inc(HOWL) | COM | 95075A107 | $7.2M | 3,398,747 | 0.4% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.1M | 179,878 | 0.4% |
| Concentra Group Holdings PAR(CON) | COMMON STOCK | 20603L102 | $6.7M | 300,000 | 0.4% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $5.9M | 101,050 | 0.3% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $5.7M | 205,073 | 0.3% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $5.7M | 77,387 | 0.3% |